Generated by DeepSeek V3.2| fibropapillomatosis | |
|---|---|
| Name | Fibropapillomatosis |
| Field | Veterinary pathology, Conservation biology, Marine biology |
| Symptoms | Cutaneous and internal tumors |
| Complications | Impaired mobility, starvation, organ failure |
| Duration | Chronic |
| Causes | Chelonid alphaherpesvirus 5 |
| Risks | Environmental co-factors |
| Diagnosis | Clinical examination, histopathology |
| Treatment | Surgical debulking, supportive care |
| Prognosis | Guarded to poor |
| Frequency | Epizootic |
fibropapillomatosis is a debilitating neoplastic disease primarily affecting marine turtles, characterized by the proliferation of benign but often life-threatening fibropapillomas. The disease is associated with infection by Chelonid alphaherpesvirus 5 and is considered a significant threat to global sea turtle populations. Research into its epidemiology and pathology is a major focus within wildlife health and conservation medicine.
The condition manifests as single or multiple epithelial tumors that can develop on the skin, eyes, and internal organs of afflicted turtles. These growths, composed of fibrous connective tissue and epithelial cells, were first documented in green sea turtles in the Florida Keys during the 1930s. The disease has since been identified as a panzootic, affecting turtles in tropical and subtropical regions worldwide. Studies from institutions like the University of Florida and the National Oceanic and Atmospheric Administration have been instrumental in characterizing its pathology.
The primary etiological agent is Chelonid alphaherpesvirus 5, a virus within the family Herpesviridae. Transmission is believed to occur horizontally through direct contact or via ectoparasites like marine leeches in the genus Ozobranchus. However, disease expression is strongly linked to environmental co-factors. Research, including work by the Hawaii Institute of Marine Biology, suggests pollution, biotoxin exposure, and compromised water quality in habitats like Kaneohe Bay may trigger viral oncogenesis. The role of ultraviolet radiation and genetic susceptibility is also under investigation.
While most prevalent in the green sea turtle, the disease has also been reported in loggerhead sea turtles, olive ridley sea turtles, and flatback sea turtles. Geographically, severe epizootics occur in Hawaii, Florida, Brazil, and Australia's Great Barrier Reef. Notable hotspots include Indian River Lagoon in Florida and Heron Island in Queensland. The Caribbean Sea and regions of the Pacific Ocean also report cases, making it a global conservation concern.
Affected turtles exhibit cutaneous tumors on the soft skin, eyes, mouth, and flippers. Internal fibropapillomas can develop on organs like the lungs, kidneys, and gastrointestinal tract. These masses can cause severe debilitation by impairing vision, feeding, and swimming, often leading to secondary bacterial infection, starvation, or drowning. Histopathological analysis reveals proliferation of dermal fibroblasts and epidermal hyperplasia. The disease burden is monitored by organizations such as the Sea Turtle Stranding and Salvage Network.
Diagnosis is primarily based on clinical presentation of characteristic tumors. Confirmatory testing involves histopathology of biopsied tissue, with techniques like polymerase chain reaction used to detect viral DNA. Treatment is largely palliative and involves surgical removal of tumors, a practice employed by rehabilitation centers like the Loggerhead Marinelife Center and the Mote Marine Laboratory. Post-operative care includes antibiotic therapy and nutritional support, though recurrence is common. No antiviral treatment or vaccine is currently available.
The disease is listed as a threat by the International Union for Conservation of Nature and significantly impacts recovery efforts for endangered species. Long-term population studies in locations like the Hawaiian Islands show reduced growth rates and survivorship in infected turtles. Major research initiatives are led by the Archie Carr Center for Sea Turtle Research, the Smithsonian Institution, and through collaborations like the Global Fibropapillomatosis Consortium. Current research focuses on viral genomics, environmental triggers, and host immune responses to develop effective management strategies.
Category:Animal diseases Category:Veterinary oncology Category:Sea turtle conservation